Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,586 recalls · Class II, newest first

Class II · Moderate risk

Phenobarbital Oral Solution

Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Terminated Labeling / mix-up Lohxa LLC NDC 70166-536-02 D-1131-2019
Class II · Moderate risk

Fayosim (levonorgestrel and ethinyl estradiol)

Failed Impurities/Degradation Specifications: Out-of-specification results observed in related substance test (Any Other Individual Impurity and Total impurities) in Ethinyl Estradiol Tablets USP 0.01mg at 12 month long term stability study.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. NDC 68180-860-11 D-1057-2019
Class II · Moderate risk

Gavilyte-N

Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

Terminated Labeling / mix-up Lupin Somerset NDC 43386-050-19 D-1113-2019
Class II · Moderate risk

Losartan 50mg Tablet

CGMP Deviations; Detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) - N-Methylnitrosobutyric acid (NMBA).

Terminated Nitrosamine impurity RemedyRepack Inc. D-1081-2019

Recalls by year